UBS Reaffirms Their Hold Rating on GlaxoSmithKline (GSK)
UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of p1,580.00. The ...
J.P. Morgan Sticks to Its Sell Rating for GlaxoSmithKline (GSK)
J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.40.
Creative Bloq on MSN11h
Nintendo just lost a trademark battle to an unexpected challenger
When you buy through links on our articles, Future and its syndication partners may earn a commission.
Rylan Clark ‘honoured’ to be announced as first ever host of 2025 Metro Pride Awards
Rylan Clark has shared his ‘honour’ at being announced as the host of the 2025 Metro Pride Awards. The TV icon will be taking on presenting duties at the star-studded event in London on 26 February, ...
Despite A Promising Future For Hutchmed, We Have Concerns About Development Of The Share Price (Rating Downgrade)
Hutchmed expects to record a gain of $477m from the deal and plans to invest the proceeds to develop its internal pipeline. See why I rate HCM stock a Hold.
MarketWatch23h
Inovio Pharmaceuticals Inc.
Merck & Co. Inc. 0.85% $248.61B ...
Indiatimes7h
GSK Pharma Share Price Returns
GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Service Income and Other Operating Revenue for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, ...